Geode Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.5K | Buy |
18,573
+226
| +1% | +$651 | ﹤0.01% | 4202 |
|
|
2025
Q1 | $55.2K | Buy |
18,347
+2,390
| +15% | +$7.19K | ﹤0.01% | 4179 |
|
|
2024
Q4 | $53.8K | Buy |
15,957
+1,474
| +10% | +$4.97K | ﹤0.01% | 4232 |
|
|
2024
Q3 | $53K | Buy |
14,483
+712
| +5% | +$2.61K | ﹤0.01% | 4255 |
|
|
2024
Q2 | $57.8K | Sell |
13,771
-23,440
| -63% | -$98.4K | ﹤0.01% | 4253 |
|
|
2024
Q1 | $26.3K | Hold |
37,211
| – | – | ﹤0.01% | 4443 |
|
|
2023
Q4 | $19.7K | Hold |
37,211
| – | – | ﹤0.01% | 4517 |
|
|
2023
Q3 | $21.9K | Buy |
+37,211
| New | +$21.9K | ﹤0.01% | 4610 |
|
|
2022
Q4 | – | Sell |
-14,008
| Closed | -$86K | – | 4914 |
|
|
2022
Q3 | $86K | Sell |
14,008
-533,120
| -97% | -$3.27M | ﹤0.01% | 4624 |
|
|
2022
Q2 | $257K | Buy |
547,128
+17,364
| +3% | +$8.16K | ﹤0.01% | 4121 |
|
|
2022
Q1 | $329K | Buy |
529,764
+5,810
| +1% | +$3.61K | ﹤0.01% | 4142 |
|
|
2021
Q4 | $791K | Buy |
523,954
+286,477
| +121% | +$432K | ﹤0.01% | 3823 |
|
|
2021
Q3 | $534K | Buy |
237,477
+222,654
| +1,502% | +$501K | ﹤0.01% | 4004 |
|
|
2021
Q2 | $53K | Hold |
14,823
| – | – | ﹤0.01% | 4649 |
|
|
2021
Q1 | $73K | Buy |
14,823
+2,167
| +17% | +$10.7K | ﹤0.01% | 4352 |
|
|
2020
Q4 | $62K | Sell |
12,656
-22,374
| -64% | -$110K | ﹤0.01% | 4130 |
|
|
2020
Q3 | $137K | Buy |
35,030
+192
| +0.6% | +$751 | ﹤0.01% | 3825 |
|
|
2020
Q2 | $168K | Buy |
34,838
+384
| +1% | +$1.85K | ﹤0.01% | 3702 |
|
|
2020
Q1 | $179K | Buy |
34,454
+768
| +2% | +$3.99K | ﹤0.01% | 3580 |
|
|
2019
Q4 | $337K | Buy |
+33,686
| New | +$337K | ﹤0.01% | 3634 |
|